SPP1 activates microglia to express C3 and C3aR, driving pathological synapse engulfment via complement. Reformulated as microglial C3aR antagonism (local CNS complement blockade) rather than systemic C3 inhibition. Leverages existing complement inhibitor platforms (pegcetacoplan TOPAZ trial, avacopan) with improved specificity. Key experiment: C3 knockdown in SPP1 KO mice to test pathway convergence vs. additivity.
Excitatory synapses on specific neuronal compartments (distal dendrites of CA1 pyramidal neurons) express low levels of membrane complement regulators CD46 and CD55, while inhibitory synapses and synapses on interneurons express high levels. During anesthesia, C1q binds preferentially to synapses lacking these regulators. Local C3a generation serves as a potent 'find-me' signal to recruiting microglia specifically to these unprotected synapses. Peptidomimetic enhancement of complement regulation
Verdict Summary
2/10
dimensions won
Complement Cascade Specificity: Microgli
8/10
dimensions won
Differential Complement Regulator Expres
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.60
0.75
Evidence
0.58
0.72
Novelty
0.55
0.75
Feasibility
0.62
0.70
Impact
0.65
0.80
Druggability
0.75
0.70
Safety
0.45
0.50
Competition
0.60
0.80
Data
0.70
0.55
Reproducible
0.68
0.72
Score Breakdown
Dimension
Complement Cascade Specificity
Differential Complement Regula
Mechanistic
0.600
0.750
Evidence
0.580
0.720
Novelty
0.550
0.750
Feasibility
0.620
0.700
Impact
0.650
0.800
Druggability
0.750
0.700
Safety
0.450
0.500
Competition
0.600
0.800
Data
0.700
0.550
Reproducible
0.680
0.720
Evidence
Complement Cascade Specificity: Microglial C3aR Antagonism D
No evidence citations yet
Differential Complement Regulator Expression on Synaptic Mem
No evidence citations yet
Debate Excerpts
Complement Cascade Specificity: Microglial C3aR An
4 rounds · quality: 0.69
Theorist
# Therapeutic Hypotheses: SPP1 in Alzheimer's Disease Synaptic Pathology
## Hypothesis 1: Stage-Dependent Biphasic SPP1 Targeting
**Title:** Early-phase SPP1 enhancement followed by late-phase SPP1 ...
Skeptic
# Critical Evaluation of SPP1 Therapeutic Hypotheses
## Overall Methodological Concerns
Before evaluating individual hypotheses, several cross-cutting issues merit attention:
**Fundamental Evidence...
Domain Expert
# Feasibility Assessment: SPP1 Therapeutic Hypotheses
## Scope and Framework
Seven hypotheses survived initial scrutiny at varying credibility levels. Two hypotheses (H1, H6) present fatal or near-f...
Synthesizer
{"ranked_hypotheses":[{"title":"TREM2-Dependent Switch Hypothesis: TREM2 Agonism Redirects SPP1 Signaling from Destructive to Restorative","description":"TREM2 haploinsufficiency shifts SPP1-mediated ...
Differential Complement Regulator Expression on Sy
4 rounds · quality: 0.75
Theorist
# Therapeutic Hypotheses: Selectivity of Complement-Mediated Synaptic Elimination During Prolonged Anesthesia
---
## Hypothesis 1: Activity-Dependent Synaptic Tagging via CREB-BDNF TrkB Signaling
*...
Skeptic
# Critical Evaluation of Hypotheses for Complement-Mediated Synaptic Selectivity
## Overview
These hypotheses address a legitimate gap in understanding how C1q distinguishes between synapses for eli...
Domain Expert
# Feasibility Assessment: Selectivity Mechanisms in Anesthesia-Induced Synaptic Elimination
## Executive Summary
The central question—whether specific synapses become targets for complement-mediated...
Synthesizer
{
"ranked_hypotheses": [
{
"title": "Differential Complement Regulator Expression on Synaptic Membranes (CD55/CD46)",
"description": "Excitatory synapses on specific neuronal compart...